CIK 0001093557 · Large accelerated filer
DEXCOM INC
Sign in to watch- Ticker
- DXCM
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330857544
- Phone
- 8582000200
- Business address
- 6340 SEQUENCE DRIVE, SAN DIEGO, CA, 92121
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,328,435
- in 8 filings, $4.3M under 10b5-1 plans
Net −$4,328,435. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- SAYER KEVIN R −$2.4M Executive Chair sold 8% of stake
- AUGUSTINOS NICHOLAS −$680K Director sold 22% of stake
- Stern Sadie −$649K EVP Chief People & Culture Off sold 6% of stake
- Sylvain Jereme M −$303K EVP, Chief Financal Officer sold 2% of stake
- Brown Michael Jon −$288K EVP Chief Legal Compliance Off sold 3% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-10-15 | FOLETTA MARK G Director | Sale | −208 | $398.25 | $83K | 14,202 |
| 2020-10-14 | DOUBLEDAY RICHARD EVP Chief Commercial Officer | Other disposition | −13,313 | 33,499 | ||
| 2020-10-14 | DOUBLEDAY RICHARD EVP Chief Commercial Officer | Other acquisition | +13,313 | 13,313 | ||
| 2020-10-11 | Malady Kyle Director | Grant or award | +1,272 | $0.00 | $1 | 1,272 |
| 2020-10-01 | Pacelli Steven Robert EVP Strategy and Corporate Dev | Sale | −200 | $420.00 | $84K | 63,018 |
| 2020-09-30 | Pacelli Steven Robert EVP Strategy and Corporate Dev | Sale | −1,900 | $410.28 | $780K | 63,318 |
| 2020-09-30 | Pacelli Steven Robert EVP Strategy and Corporate Dev | Sale | −100 | $411.10 | $41K | 63,218 |
| 2020-09-25 | Pacelli Steven Robert EVP Strategy and Corporate Dev | Sale | −2,000 | $400.07 | $800K | 65,218 |
| 2020-09-24 | DOUBLEDAY RICHARD EVP Chief Commercial Officer | Sale | −100 | $380.31 | $38K | 1,430 |
| 2020-09-24 | DOUBLEDAY RICHARD EVP Chief Commercial Officer | Sale | −1,430 | $381.00 | $545K | 0 |
| 2020-09-23 | Pacelli Steven Robert EVP Strategy and Corporate Dev | Sale | −1,079 | $395.11 | $426K | 67,218 |
| 2020-09-16 | AUGUSTINOS NICHOLAS Director | Sale | −124 | $396.51 | $49K | 15,593 |
| 2020-09-16 | AUGUSTINOS NICHOLAS Director | Sale | −66 | $398.11 | $26K | 15,527 |
| 2020-09-16 | AUGUSTINOS NICHOLAS Director | Sale | −1,471 | $399.84 | $588K | 14,056 |
| 2020-09-16 | AUGUSTINOS NICHOLAS Director | Sale | −88 | $400.94 | $35K | 13,968 |
| 2020-09-16 | AUGUSTINOS NICHOLAS Director | Sale | −126 | $402.49 | $51K | 13,842 |
| 2020-09-15 | ALTMAN STEVEN R Director | Sale | −30,000 | $393.92 | $11.8M | 12,980 |
| 2020-09-15 | Balo Andrew K * | Sale | −5,256 | $397.35 | $2.1M | 35,567 |
| 2020-09-14 | FOLETTA MARK G Director | Sale | −3 | $386.21 | $1K | 16,199 |
| 2020-09-14 | FOLETTA MARK G Director | Sale | −109 | $390.86 | $43K | 16,090 |
Page 47 of 55 · 1,082 trades